Monashee Investment Management LLC Ambrx Biopharma Inc. Transaction History

Monashee Investment Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$9.3 - $16.6 $651,000 - $1.16 Million	70,000 New	70,000 $805,000
Q3 2021 Nov 09, 2021	SELL	$13.31 - $22.53 $1.46 Million - $2.48 Million	-110,000 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$15.95 - $19.6 $1.75 Million - $2.16 Million	110,000 New	110,000 $2.16 Million

31.2K

Ticker AMAM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,618,400
Market Cap $1.08B
Description
Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gas...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.